The last thing you want when traveling is a major illness to derail the trip. Baylor College of Medicine infectious disease ...

The Global Alcohol Disinfectants Market, valued at approximately USD 2.71 billion in 2023, is forecasted to grow at a robust compound annual growth rate (CAGR) of 11.5% over the period 2024 to 2032, ...

A deadly hospital bug, *C. difficile*, is more dangerous due to its CDT toxin. Scientists now understand how this toxin builds itself, revealing crucial targets for new drugs to block its action and ...

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is often perceived as a condition ...

British researchers who tested almost 1,000 patients with the allergy, found almost 90 per cent could actually safely use the drug.

More scientific evidence is emerging to show that our gastrointestinal system interacts with our nervous system ...

But because fecal transplant addresses the root cause of the infection, researchers suspected it might be effective as a front-line treatment for C. difficile.

But because fecal transplant addresses the root cause of the infection, researchers suspected it might be effective as a front-line treatment for C. difficile.

Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections Ian R Poxton Disclosures Future Virology. 2010;5 (4):539-548.